Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167–73.
Debourdeau E, Builles N, Couderc G, Boulhic J, Chamard C, Villain M, et al. Risk factors of rejection after penetrating keratoplasty: a retrospective monocentric study. Graefes Arch Clin Exp Ophthalmol. 2022;260(11):3627–38.
Yu AL, Kaiser M, Schaumberger M, Messmer E, Kook D, Welge-Lussen U. Donor-related risk factors and preoperative recipient-related risk factors for graft failure. Cornea. 2014;33(11):1149–56.
Alio JL, Montesel A, El Sayyad F, Barraquer RI, Arnalich-Montiel F, Alio Del Barrio JL. Corneal graft failure: an update. Br J Ophthalmol. 2021;105(8):1049–58.
Amouzegar A, Chauhan SK, Dana R. Alloimmunity and tolerance in corneal transplantation. J Immunol. 2016;196(10):3983–91.
Article PubMed CAS Google Scholar
Hos D, Matthaei M, Bock F, Maruyama K, Notara M, Clahsen T, et al. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019;73:100768.
Article PubMed CAS Google Scholar
Zhong W, Montana M, Santosa SM, Isjwara ID, Huang Y-H, Han K-Y, et al. Angiogenesis and lymphangiogenesis in corneal transplantation—a review. Surv Ophthalmol. 2018;63(4):453–79.
Hou Y, Bock F, Hos D, Cursiefen C. Lymphatic trafficking in the eye: modulation of lymphatic trafficking to promote corneal transplant survival. Cells. 2021;10(7):1661.
Article PubMed PubMed Central CAS Google Scholar
Dohlman TH, Omoto M, Hua J, Stevenson W, Lee S-M, Chauhan SK, et al. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation. Transplantation. 2015;99(4):678–86.
Article PubMed CAS Google Scholar
Tahvildari M, Amouzegar A, Foulsham W, Dana R. Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation. Cell Mol Life Sci. 2018;75(9):1509–20.
Article PubMed PubMed Central CAS Google Scholar
Yu K, Lian X-F, Jiang X-Y, Zhou S-Y. Efficacy of immunosuppressants in high rejection risk keratoplasty: a meta-analysis of comparative studies. Cornea. 2021;40(6):800–7.
Chen X, Huang J, Wu J, Hao J, Fu B, Wang Y, et al. Human mesenchymal stem cells. Cell Prolif. 2022;55(4):e13141.
Article PubMed CAS Google Scholar
Lu X, Ru Y, Chu C, Lv Y, Gao Y, Jia Z, et al. Lentivirus-mediated IL-10-expressing bone marrow mesenchymal stem cells promote corneal allograft survival upregulating lncRNA 003946 in a rat model of corneal allograft rejection. Theranostics. 2020;10(18):8446–67.
Article PubMed PubMed Central CAS Google Scholar
Sarsenova M, Kim Y, Raziyeva K, Kazybay B, Ogay V, Saparov A. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol. 2022;13:1010399.
Article PubMed PubMed Central CAS Google Scholar
Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, et al. Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells. 2008;26(11):2865–74.
Article PubMed CAS Google Scholar
Harasymiak-Krzyżanowska I, Niedojadło A, Karwat J, Kotuła L, Gil-Kulik P, Sawiuk M, et al. Adipose tissue-derived stem cells show considerable promise for regenerative medicine applications. Cell Mol Biol Lett. 2013;18(4):479–93.
Article PubMed PubMed Central Google Scholar
Tan K, Zheng K, Li D, Lu H, Wang S, Sun X. Impact of adipose tissue or umbilical cord derived mesenchymal stem cells on the immunogenicity of human cord blood derived endothelial progenitor cells. PLoS ONE. 2017;12(5):e0178624.
Article PubMed PubMed Central Google Scholar
Ansari S, Chen C, Hasani-Sadrabadi MM, Yu B, Zadeh HH, Wu BM, et al. Hydrogel elasticity and microarchitecture regulate dental-derived mesenchymal stem cell-host immune system cross-talk. Acta Biomater. 2017;60:181–9.
Article PubMed PubMed Central CAS Google Scholar
Shin S, Lee J, Kwon Y, Park K-S, Jeong J-H, Choi S-J, et al. Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and Wharton’s jelly. Int J Mol Sci. 2021;22(2):845.
Article PubMed PubMed Central CAS Google Scholar
Hua J, Yu H, Dong W, Yang C, Gao Z, Lei A, et al. Characterization of mesenchymal stem cells (MSCs) from human fetal lung: potential differentiation of germ cells. Tissue Cell. 2009;41(6):448–55.
Article PubMed CAS Google Scholar
Ghanta S, Kwon M-Y, Rosas IO, Liu X, Perrella MA. Mesenchymal stromal cell therapy: Does the source matter? Crit Care Med. 2018;46(2):343–5.
Article PubMed PubMed Central Google Scholar
Heo JS, Choi Y, Kim H-S, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37(1):115–25.
Bunnell BA. Adipose tissue-derived mesenchymal stem cells. Cells. 2021;10(12):3433.
Article PubMed PubMed Central Google Scholar
Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, et al. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol. 2011;270(2):207–16.
Article PubMed CAS Google Scholar
Ding D-C, Chang Y-H, Shyu W-C, Lin S-Z. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339–47.
Sun Q, Huang Z, Han F, Zhao M, Cao R, Zhao D, et al. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial. J Transl Med. 2018;16(1):52.
Article PubMed PubMed Central CAS Google Scholar
Gou W, Hua W, Swaby L, Cui W, Green E, Morgan KA, et al. Stem cell therapy improves human islet graft survival in mice via regulation of macrophages. Diabetes. 2022;71(12):2642–55.
Article PubMed CAS Google Scholar
Podestà MA, Remuzzi G, Casiraghi F. Mesenchymal stromal cells for transplant tolerance. Front Immunol. 2019;10:1287.
Article PubMed PubMed Central Google Scholar
Treacy O, Lynch K, Murphy N, Chen X, Donohoe E, Canning A, et al. Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice. Stem Cell Res Ther. 2021;12(1):227.
Article PubMed PubMed Central CAS Google Scholar
Lynch K, Treacy O, Chen X, Murphy N, Lohan P, Islam MN, et al. TGF-β1-Licensed murine MSCs show superior therapeutic efficacy in modulating corneal allograft immune rejection in vivo. Mol Ther J Am Soc Gene Ther. 2020;28(9):2023–43.
Hjortdal J. Adverse immune signatures and their prevention in corneal transplantation: a presentation and update on the VISICORT project. Invest Ophthalmol Vis Sci. 2016;57(12):1231–1231.
Niemeyer P, Vohrer J, Schmal H, Kasten P, Fellenberg J, Suedkamp NP, et al. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy. 2008;10(8):784–95.
Article PubMed CAS Google Scholar
Ren Y, Dong X, Zhao H, Feng J, Chen B, Zhou Y, et al. Myeloid-derived suppressor cells improve corneal graft survival through suppressing angiogenesis and lymphangiogenesis. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2021;21(2):552–66.
Yardeni T, Eckhaus M, Morris HD, Huizing M, Hoogstraten-Miller S. Retro-orbital injections in mice. Lab Anim (NY). 2011;40(5):155–60.
Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77(3):370–6.
Article PubMed CAS Google Scholar
Murphy WJ, Nolta JA. Autoimmune T cells lured to a FASL web of death by MSCs. Cell Stem Cell. 2012;10(5):485–7.
留言 (0)